ARS Investment Partners LLC Sells 53,030 Shares of Lam Research Corporation $LRCX

ARS Investment Partners LLC lowered its position in Lam Research Corporation (NASDAQ:LRCX) by 10.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 439,100 shares of the semiconductor company’s stock after selling 53,030 shares during the quarter. Lam Research accounts for 3.9% of ARS Investment Partners LLC’s investment portfolio, making the stock its 4th biggest position. ARS Investment Partners LLC’s holdings in Lam Research were worth $58,795,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. IMG Wealth Management Inc. acquired a new position in Lam Research during the second quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new position in shares of Lam Research in the 2nd quarter valued at $27,000. Sound Income Strategies LLC acquired a new position in shares of Lam Research during the 3rd quarter valued at $41,000. Strategic Wealth Investment Group LLC acquired a new position in shares of Lam Research during the 2nd quarter valued at $29,000. Finally, Delos Wealth Advisors LLC purchased a new stake in Lam Research during the 2nd quarter worth $30,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Insiders Place Their Bets

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This represents a 44.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the sale, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 102,608 shares of company stock valued at $14,916,496 in the last quarter. 0.31% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on LRCX shares. New Street Research upped their target price on Lam Research from $105.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. JPMorgan Chase & Co. upped their price target on Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a report on Thursday, October 23rd. TD Cowen increased their price objective on shares of Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. HSBC set a $127.00 target price on shares of Lam Research and gave the stock a “hold” rating in a research report on Tuesday, September 30th. Finally, Oppenheimer set a $200.00 price target on shares of Lam Research and gave the company an “outperform” rating in a report on Thursday, October 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $161.21.

Lam Research Stock Up 1.2%

Shares of NASDAQ:LRCX opened at $177.24 on Thursday. The firm has a market cap of $222.62 billion, a PE ratio of 39.04, a price-to-earnings-growth ratio of 2.02 and a beta of 1.77. The company has a fifty day simple moving average of $156.96 and a 200 day simple moving average of $124.97. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $177.56.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same period in the previous year, the company earned $0.86 earnings per share. Lam Research’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities research analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. Lam Research’s payout ratio is currently 22.91%.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.